Desai Mansi, Caldwell Katherine, Gupta Nisha, Bekmezian Arpi, Cabana Michael D, Auerbach Andrew D, Kaiser Sunitha V
Department of Pediatrics, University of California, San Francisco, California.
Department of Epidemiology and Biostatistics, University of California, San Francisco, California.
Pediatr Qual Saf. 2020 Oct 26;5(6):e355. doi: 10.1097/pq9.0000000000000355. eCollection 2020 Nov-Dec.
Pathways guide clinicians through evidence-based care of specific conditions. Pathways have been demonstrated to improve pediatric asthma care, but mainly in studies at tertiary children's hospitals. Our global aim was to enhance the quality of asthma care across multiple measures by implementing pathways in community hospitals.
This quality improvement study included children ages 2-17 years with a primary diagnosis of asthma. Data were collected before and after pathway implementation (total 28 mo). Pathway implementation involved local champions, educational meetings, audit/feedback, and electronic health record integration. Emergency department (ED) measures included severity assessment at triage, timely systemic corticosteroid administration (within 60 mins), chest radiograph (CXR) utilization, hospital admission, and length of stay (LOS). Inpatient measures included screening for secondhand tobacco and referral to cessation resources, early administration of bronchodilator via metered-dose inhaler, antibiotic prescription, LOS, and 7-day readmission/ED revisit. Analyses were done using statistical process control.
We analyzed 881 ED visits and 138 hospitalizations from 2 community hospitals. Pathways were associated with increases in the proportion of children with timely systemic corticosteroid administration (Site 1: 32%-57%, Site 2: 62%-75%) and screening for secondhand tobacco (Site 1: 82%-100%, Site 2: 54%-89%); and decreases in CXR utilization (Site 1: 44%-29%), ED LOS (Site 1: 230-197 mins), and antibiotic prescription (Site 2: 23%-3%). There were no significant changes in other outcomes.
Pathways improved pediatric asthma care quality in the ED and inpatient settings of community hospitals.
临床路径指导临床医生对特定疾病进行循证治疗。临床路径已被证明可改善儿童哮喘护理,但主要是在三级儿童医院的研究中。我们的总体目标是通过在社区医院实施临床路径,从多个方面提高哮喘护理质量。
这项质量改进研究纳入了2至17岁初诊为哮喘的儿童。在临床路径实施前后收集数据(共28个月)。临床路径的实施包括当地负责人、教育会议、审核/反馈以及电子健康记录整合。急诊科指标包括分诊时的严重程度评估、及时给予全身糖皮质激素(60分钟内)、胸部X光片(CXR)使用情况、住院、住院时间(LOS)。住院指标包括二手烟筛查及转诊至戒烟资源处、通过定量吸入器早期给予支气管扩张剂、抗生素处方、住院时间以及7天内再入院/急诊复诊。分析采用统计过程控制。
我们分析了来自2家社区医院的881次急诊就诊和138例住院病例。临床路径与及时给予全身糖皮质激素的儿童比例增加(地点1:32% - 57%,地点2:62% - 75%)以及二手烟筛查比例增加(地点1:82% - 100%,地点2:54% - 89%)相关;与胸部X光片使用情况减少(地点1:44% - 29%)、急诊住院时间减少(地点1:230 - 197分钟)以及抗生素处方减少(地点2:23% - 3%)相关。其他结果无显著变化。
临床路径改善了社区医院急诊科和住院部的儿童哮喘护理质量。